Clinical Reference Library
Clinical Research & Reference Library
Released: Last reviewed:
Peer-reviewed deep dives into every major GLP-1 receptor agonist clinical trial, mechanism, safety topic, and special-population consideration. 41 clinical reference pages with 210+ peer-reviewed citations across the library.
Editorial summary
The GLP1 One Rx clinical library is organized into five categories: foundational mechanism & pharmacology, major trial deep-dives, safety & adverse events, special populations, and comparisons & long-term outcomes. Every page is medically reviewed by Dr. Jonathan Snipes, MD and Kim Callender, NP (FNP-BC), cites peer-reviewed sources with live PubMed links, and is structured for AI-assistant snippet extraction.
Foundational mechanism & pharmacology
Major trial deep-dives
- STEP 1 Trial Semaglutide Obesity
- STEP 2 Trial Semaglutide T2D
- STEP 3 Trial Intensive Behavioral
- STEP 4 Trial Continued Treatment
- STEP 5 Trial Two Year
- STEP HFPEF Trial Heart Failure
- STEP Trial Results
- SURMOUNT 1 Trial Tirzepatide Obesity
- SURMOUNT 3 Trial Intensive Lifestyle
- SELECT Trial Cardiovascular Outcomes
- SELECT Trial Results
- SUSTAIN Trial Results
- FLOW Trial Results
- FLOW Trial Semaglutide Kidney Disease